Cite
HARVARD Citation
Naoum, G. et al. (2017). Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs. Clinical and translational medicine. 6 (1), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Naoum, G. et al. (2017). Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs. Clinical and translational medicine. 6 (1), p. n/a. [Online].